用电治疗帕金森病相关的冷漠:一个病例报告
Kiyori Yamanaka1, Ryo Mizui1, Yuki Noriyama1
1Department of Psychiatry Nara Medical University School of Medicine Kashihara Japan.
PCN reports : psychiatry and clinical neurosciences
|August 25, 2025
概括
电疗法可以有效治疗帕金森病 (PD) 的非运动症状 - - 无动感. 这项病例研究显示,经过修改ECT (m-ECT) 后,无意识症状显著改善,没有认知副作用.
科学领域:
- 神经学
- 精神病学
背景情况:
- 非运动症状显著影响帕金森病 (PD) 的治疗.
- 无动于衷,减少目标导向的活动,影响40%的PD患者,损害生活质量.
- 电治疗 (ECT) 对于PD的抑郁症有效,但对其对冷漠的使用尚未进行研究.
研究的目的:
- 评估改性电疗法 (m-ECT) 在治疗帕金森病患者严重冷漠的潜在疗效.
主要方法:
- 一个54岁的男性患有帕金森病,
- 药物治疗是无效的;进行了修改后的ECT (m-ECT) (10次5周).
主要成果:
- 患者的冷漠度显著改善,在冷漠度尺度上得分从32降至12.
- 治疗后没有观察到对认知功能的不良影响.
结论:
- 改性ECT (m-ECT) 显示为对帕金森病无动于衷的治疗方法.
- 需要进行进一步的研究,以探索心电疗法的非运动性症状的机制和长期结果.
相关概念视频
Electroconvulsive Therapy
185
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
185
Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703


